Company or institution

ASTRAZENECA UK LIMITED

Save Like

83 applicationsfiled 2007 to 2025

Allowance rate

50%

−25 pts vs the USPTO range 39% to 61%

Rejections before allowance

1.1

−0.5 vs the USPTO

Months to first action

15.6 mo

−3.0 vs the USPTO

Needed an RCE

15%

−12 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

G16H Healthcare informatics23 apps

A61K Medical preparations23 apps

C07D Heterocyclic compounds21 apps

A61P Therapeutic activity of compounds7 apps

C07K Peptides3 apps

A61M Devices for introducing media into the body2 apps

Art units

162419 apps

368615 apps

16119 apps

36267 apps

OPAP4 apps

16753 apps

Examiners met

The examiners seen most, and how it went with each

Devin C Hein8 apps

100%

Peter Anthopolos6 apps

Venkataraman Balasubramanian5 apps

60%

Constantine B Siozopoulos5 apps

80%

Docket Central4 apps

n/a

Susanna Moore4 apps

25%

Karen Amanda Hranek3 apps

67%

Jeffrey H Murray3 apps

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

Morgan, Lewis & Bockius LLP (SF)24 apps

79%

ASTRAZENECA MEDIMMUNE18 apps

25%

Morgan, Lewis & Bockius LLP (WA)13 apps

46%

STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.8 apps

20%

NIXON & VANDERHYE, PC6 apps

FOLEY & LARDNER LLP4 apps

n/a

ASTRAZENECA PHARMACEUTICALS LP3 apps

67%

FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER2 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19484904	Treatment of Corticosteroid Dependent Asthma with Anti-TSLP Antibody	2025-11-17	Pending	0	0	n/a
19380185	SARS-COV-2 ANTIBODIES AND METHODS OF USING THE SAME	2025-11-05	Pending	0	0	n/a
19222453	COMBINATION OF ANTIBODY-DRUG CONJUGATES AND DNMT INHIBITORS	2025-05-29	Pending	0	0	n/a
15690521	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15670656	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15340482	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15796875	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15654698	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15626780	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15394577	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 83 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in